Northwestern Mutual Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,314	Closed	-$47.7K	–	4023
2025 Q3	$47.7K	Buy	+4,314	New	+$47.1K	﹤0.01%	2340
2023 Q4	–	Sell	-374	Closed	-$2.91K	–	3478
2023 Q3	$2.91K	Buy	+374	New	+$3.66K	﹤0.01%	2887
2023 Q2	–	Sell	-2,500	Closed	-$27.4K	–	3349
2023 Q1	$27.4K	Buy	+2,500	New	+$22K	﹤0.01%	2156
2021 Q2	–	Sell	-400	Closed	-$5K	–	2986
2021 Q1	$5K	Buy	+400	New	+$5.8K	﹤0.01%	2443
2019 Q3	–	Sell	-1,950	Closed	-$13K	–	2458
2019 Q2	$13K	Buy	+1,950	New	+$12.4K	﹤0.01%	1859

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northwestern Mutual Wealth Management's AUPH Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 4,314 shares — an estimated $47.7K sold.

Northwestern Mutual Wealth Management first reported a position in AUPH in Q2 2019 and held it in 5 quarters. The position peaked at $47.7K in Q3 2025. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

Northwestern Mutual Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 4,314 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $47.7K.
Northwestern Mutual Wealth Management first reported a position in Aurinia Pharmaceuticals in Q2 2019 and held it in 5 quarters.
Northwestern Mutual Wealth Management's Aurinia Pharmaceuticals position peaked at $47.7K in Q3 2025.
255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.